1. Liaoning Future Biotechnology Co., Ltd. is a joint-stock company controlled by Liaoning Institute of Biomedical Engineering. Is a high-tech biotechnology enterprise dedicated to human health industry, mainly engaged in research and development, production and sales of biological products (health food, food, biopharmaceuticals). FutureBiotechInc is a wholly-owned subsidiary of the company in the United States. At the beginning of 20 10, it settled in Du Yao, China, Benxi, Liaoning Province (National Biomedical Science and Technology Industrial Base), with a registered capital of 84.45 million yuan, covering an area of 170 mu, and a total investment of 210 million yuan. It is one of the largest production bases of antioxidant enzymes in China.
2. The company has excellent biotechnology talents, advanced technical equipment and strong economic strength. In 2003, the method of extracting compound antioxidant enzyme from corn germ was patented by the state, and the closed biological extraction technology of quantitative production was the first in the world, and the national patent was applied on 14. The compound antioxidant enzyme "Yuannuo Capsule" produced by this patented technology has passed the certification of domestic authoritative organization China, US Food and Drug Administration and international authoritative organization FDA. The effects of certification are: delaying aging, improving sleep quality and enhancing health immunity.